She had been given hygiene advice for four years. It was never a hygiene problem.
Where she started
Four years of recurrent painful nodules beneath both breasts. Intermittent pus discharge, worse with sweating. Burning and redness from moisture and friction. Early thickened scarring from repeated inflammation. Discomfort walking and bending. Difficulty wearing fitted innerwear. Symptoms that reliably worsened in warm weather.
Inframammary HS is one of the most under-recognised presentations of the disease, and one of the most consistently misread. Because the site is warm, damp and subject to friction, it is repeatedly explained as intertrigo, as a fungal problem, or — with a particular kind of casual cruelty — as a hygiene issue.
She had been given antifungals. She had been given hygiene advice. For four years.
It was never a hygiene problem. HS occurs in apocrine-bearing skin, and the under-breast region is apocrine-bearing skin. Friction and heat are aggravators of a systemic process — they are not its cause. Treating the aggravator while leaving the process untouched is precisely why nothing held.
What the evaluation found
Alongside the lesions, two things she had never been asked about and had never thought to mention: bloating and heaviness after meals, and a flare pattern that tracked her cycle.
Those two facts reframed the case. A gut generating an inflammatory signal, a hormonal driver amplifying it — with insulin resistance raising free androgens and lowering the threshold for follicular involvement — and a metabolic background state that kept the whole system primed.
The under-breast lesions were the last link in that chain, not the first.
What treatment actually was
Phase L — oral formulations reducing accumulated inflammatory load and restoring digestive function. Her bloating and post-meal heaviness resolved in this phase, which she had assumed was simply how she digested food.
Phase I — gut barrier restoration and microbiome repair, with hormonal and metabolic recalibration running alongside. For her driver profile, this was the phase that changed the disease.
Phase F — internal clearance, oral, sequenced third.
Phase E — topical formulations for lesion resolution and barrier restoration, and for the specific problem of a site that is chronically warm and moist. Practical guidance on friction, heat and clothing sat here too — not as the treatment, but as sensible support for it. That distinction is the whole difference between what she had been given before and what she was given now.
Phase S — tapering and monitoring.
How it unfolded
Digestion first, within weeks. Sleep next, as active flares became less disruptive. Then the pattern she had lived with for four years began to change: fewer lesions, less discharge, and — the marker that mattered most to her — flares that no longer arrived on a schedule she could predict from her calendar.
By the later phases: no new nodules, existing lesions healed without rupture, the burning and irritation resolved, and the early scarring softened. She could wear what she wanted to wear.
The seasonal pattern — reliably worse in the heat — did not disappear entirely. Heat is a real aggravator and it remains one. What changed is that it stopped being able to trigger a flare on its own, because the underlying inflammatory state it used to act on was no longer there. That is Recovery Stage 3: the same trigger, a diminished response.
Why this one matters
If you have under-breast lesions and you have been handed an antifungal cream and a lecture about keeping the area dry, this is the story to read.
Inframammary HS is HS. It is systemic. It is driven by the gut, hormones and metabolism like every other presentation of the disease, and it responds to the same correction — provided somebody asks about your digestion and your cycle instead of your washing.
